Table 1: Laboratory data
before regorafenib administration.
WBC |
2900/mL |
TP |
6.9 g/dL |
UA |
3.9 mg/dL |
Neutrophil |
1343/mL |
Alb |
3.9 g/dL |
Na |
140 mEq/L |
Lymphocyte |
1154/mL |
T-Bil |
1.3 mg/dL |
K |
3.5 mEq/L |
Monocyte |
322/mL |
D-Bil |
0.2 mg/dL |
Cl |
105 mEq/L |
Eosinocyte |
81/mL |
AST |
28 IU/L |
Ca |
9.6 mg/dL |
Hb |
12.4 g/dL |
ALT |
18 IU/L |
FPG |
126 mg/dL |
RBC |
390 × 104/mL |
LDH |
198 IU/L |
HbA1c |
5.60% |
Ht |
37.00% |
GGT |
27 IU/L |
CRP |
0.26 mg/dL |
Platelet |
14.3 × 103/mL |
ALP |
370 IU/L |
CRP |
0.26 mg/dL |
PT-INR |
1.02 |
BUN |
11 mg/dL |
CEA |
676.4 ng/mL |
APTT |
27.1 s |
Cre |
0.51 mg/dL |
CA 19-9 |
65.6 U/mL |